Most sold healthcare stocks in Q2 2025
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q2 2025 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include HALEON PLC-ADR (HLN), NEKTAR THERAPEUTICS (NKTR), PFIZER INC (PFE), ORGANON & CO (OGN). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| HLN | HALEON PLC-ADR | -6,895,485 | -$57.6M | 1 | 4 | 4 | 1 | 10 |
| NKTR | NEKTAR THERAPEUTICS | -4,701,988 | -$3.2M | 0 | 0 | 0 | 2 | 0 |
| PFE | PFIZER INC | -4,156,615 | -$129.0M | 2 | 11 | 14 | 7 | 30 |
| OGN | ORGANON & CO | -4,009,874 | -$79.3M | 0 | 1 | 3 | 3 | 7 |
| MYGN | MYRIAD GENETICS INC | -3,778,493 | -$37.9M | 0 | 2 | 1 | 0 | 4 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -3,629,813 | $117.4M | 1 | 0 | 2 | 0 | 4 |
| OSCR | OSCAR HEALTH INC - CLASS A | -3,577,863 | -$26.4M | 4 | 3 | 2 | 1 | 10 |
| OCGN | OCUGEN INC | -3,459,283 | -$2.4M | 0 | 0 | 0 | 1 | 0 |
| ALHC | ALIGNMENT HEALTHCARE INC | -3,220,832 | -$71.5M | 0 | 2 | 0 | 2 | 2 |
| BBIO | BRIDGEBIO PHARMA INC | -3,218,775 | $50.9M | 2 | 0 | 2 | 0 | 4 |
| BMY | BRISTOL-MYERS SQUIBB CO | -3,217,596 | -$669.6M | 3 | 11 | 9 | 4 | 26 |
| TVTX | TRAVERE THERAPEUTICS INC | -2,809,622 | -$58.1M | 0 | 0 | 1 | 1 | 1 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -2,429,156 | -$26.4M | 2 | 0 | 6 | 2 | 9 |
| CI | THE CIGNA GROUP | -2,271,692 | -$731.0M | 0 | 8 | 7 | 2 | 18 |
| CVS | CVS HEALTH CORP | -2,126,904 | -$25.1M | 2 | 10 | 9 | 1 | 24 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,120,548 | -$150.9M | 1 | 7 | 5 | 2 | 15 |
| SENS | SENSEONICS HOLDINGS INC | -2,102,262 | -$1.9M | 0 | 0 | 1 | 1 | 1 |
| ENZ | ENZO BIOCHEM INC | -2,085,029 | -$771.5K | 0 | 0 | 0 | 2 | 0 |
| CERS | CERUS CORP | -2,040,714 | -$2.4M | 1 | 0 | 3 | 0 | 4 |
| GILD | GILEAD SCIENCES INC | -2,025,572 | -$274.6M | 3 | 11 | 6 | 4 | 20 |
| LYEL | LYELL IMMUNOPHARMA INC | -1,768,500 | -$951.5K | 0 | 0 | 0 | 1 | 0 |
| RXRX | RECURSION PHARMACEUTICALS-A | -1,767,120 | -$17.0M | 0 | 2 | 2 | 1 | 4 |
| QSI | QUANTUM-SI INC | -1,535,785 | $4.3M | 0 | 0 | 4 | 0 | 5 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -1,534,323 | -$8.6M | 0 | 0 | 1 | 0 | 1 |
| DVA | DAVITA INC | -1,354,098 | -$564.4M | 0 | 3 | 2 | 0 | 6 |
| SNY | SANOFI-ADR | -1,338,228 | -$596.8M | 1 | 9 | 3 | 1 | 13 |
| HOLX | HOLOGIC INC | -1,309,207 | -$70.1M | 1 | 4 | 4 | 4 | 10 |
| TRVI | TREVI THERAPEUTICS INC | -1,284,392 | -$9.7M | 0 | 1 | 1 | 0 | 2 |
| IMVT | IMMUNOVANT INC | -1,269,327 | -$22.0M | 0 | 0 | 1 | 1 | 1 |
| NVRO | NEVRO CORP | -1,209,409 | -$7.1M | 0 | 0 | 0 | 1 | 0 |
| NVS | NOVARTIS AG-SPONSORED ADR | -1,159,624 | -$3.7M | 1 | 5 | 5 | 1 | 14 |
| KRON | KRONOS BIO INC | -1,102,326 | -$909.4K | 0 | 0 | 0 | 1 | 0 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -1,053,937 | $41.8M | 0 | 1 | 2 | 0 | 3 |
| A | AGILENT TECHNOLOGIES INC | -1,039,486 | -$117.2M | 1 | 3 | 6 | 2 | 11 |
| PRME | PRIME MEDICINE INC | -1,020,525 | -$808.3K | 0 | 0 | 2 | 1 | 3 |
| OGI | ORGANIGRAM HOLDINGS INC | -1,004,748 | -$1.0M | 0 | 0 | 0 | 1 | 0 |
| SYK | STRYKER CORP | -1,002,479 | -$139.2M | 1 | 9 | 10 | 2 | 24 |
| VTYX | VENTYX BIOSCIENCES INC | -945,089 | -$1.0M | 0 | 0 | 1 | 0 | 1 |
| SOLV | SOLVENTUM CORP | -943,742 | $6.5M | 1 | 6 | 0 | 2 | 12 |
| ABSI | ABSCI CORP | -909,161 | -$1.7M | 0 | 0 | 1 | 0 | 1 |
| RPTX | REPARE THERAPEUTICS INC | -900,285 | -$676.3K | 0 | 1 | 0 | 1 | 1 |
| ALLK | ALLAKOS INC | -869,311 | -$197.9K | 0 | 0 | 0 | 1 | 0 |
| WRBY | WARBY PARKER INC-CLASS A | -856,799 | $27.7M | 0 | 1 | 3 | 1 | 5 |
| PAHC | PHIBRO ANIMAL HEALTH CORP-A | -805,592 | -$14.6M | 1 | 0 | 1 | 1 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -709,872 | -$29.3M | 2 | 1 | 3 | 2 | 7 |
| CMRX | CHIMERIX INC | -689,249 | -$5.9M | 0 | 0 | 0 | 1 | 0 |
| DCGO | DOCGO INC | -682,647 | -$2.2M | 0 | 0 | 1 | 1 | 2 |
| RAPT | RAPT THERAPEUTICS INC | -648,823 | -$791.6K | 0 | 0 | 0 | 1 | 0 |
| RLAY | RELAY THERAPEUTICS INC | -638,704 | -$298.0K | 2 | 0 | 1 | 0 | 3 |
| AGL | AGILON HEALTH INC | -625,909 | -$4.5M | 0 | 1 | 1 | 1 | 3 |